高级检索
    刘晓晴, 范杰, 黄淑梅. 靶向肿瘤KRAS 突变的T细胞过继免疫治疗[J]. 循证医学, 2017, 17(1): 37-41. DOI: 10.12019/j.issn.1671-5144.2017.01.011
    引用本文: 刘晓晴, 范杰, 黄淑梅. 靶向肿瘤KRAS 突变的T细胞过继免疫治疗[J]. 循证医学, 2017, 17(1): 37-41. DOI: 10.12019/j.issn.1671-5144.2017.01.011
    shu
    LIU Xiao-qing, FAN Jie, HUANG Shu-mei. T-Cell Transfer Immunological Therapy Targeting Mutant KRAS in Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(1): 37-41. DOI: 10.12019/j.issn.1671-5144.2017.01.011
    Citation: LIU Xiao-qing, FAN Jie, HUANG Shu-mei. T-Cell Transfer Immunological Therapy Targeting Mutant KRAS in Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(1): 37-41. DOI: 10.12019/j.issn.1671-5144.2017.01.011
    shu

    靶向肿瘤KRAS 突变的T细胞过继免疫治疗

    T-Cell Transfer Immunological Therapy Targeting Mutant KRAS in Cancer

      摘要
      • HTML全文
      • 参考文献(3)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回